Takeda Pharmaceutical Company Limited
4502
Clasificación en acciones
#375
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Precio por acción
$40.45
Capitalización bursátil
$64.36B
Cambio (1 día)
1.19%
Cambio (1 año)
43.11%
País
JP
Comercio Takeda Pharmaceutical Company Limited (4502)
Categoría
Healthcare
Historial del precio de la acción de Takeda Pharmaceutical Company Limited (4502)
Precio más alto de cierre: $38.84 el 2026-10-01
Precio más bajo de cierre: $15.37 el 1990-01-01
Precio más bajo de cierre: $15.37 el 1990-01-01
Historial del precio de la acción de Takeda Pharmaceutical Company Limited desde 1990 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | 16.58% |
| 2025 | 9.81% |
| 2024 | -4.74% |
| 2023 | -6.93% |
| 2022 | 10.67% |
| 2021 | -25.73% |
| 2020 | -8.85% |
| 2019 | 17.44% |
| 2018 | -38.14% |
| 2017 | 35.62% |
| 2016 | -15.67% |
| 2015 | 15.94% |
| 2014 | -13.88% |
| 2013 | 6.22% |
| 2012 | 10.14% |
| 2011 | -12.31% |
| 2010 | 13.40% |
| 2009 | -15.52% |
| 2008 | -16.70% |
| 2007 | -10.91% |
| 2006 | 20.85% |
| 2005 | 12.27% |
| 2004 | 25.62% |
| 2003 | -3.39% |
| 2002 | -8.53% |
| 2001 | -25.89% |
| 2000 | 8.44% |
| 1999 | 100.05% |
| 1998 | 14.68% |
| 1997 | 57.21% |
| 1996 | 45.92% |
| 1995 | 33.20% |
| 1994 | 4.32% |
| 1993 | -8.10% |
| 1992 | -2.51% |
| 1991 | -23.26% |
| 1990 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $162.33 | 21.40% |
DE
|
|
| $222.74 | 30.07% |
CH
|
|
| $18.48 | -3.76% |
IN
|
|
| $6.89 | -24.78% |
CN
|
